Avinger, Inc. (AVGR) Shares Gap Up to $0.35
Avinger, Inc. (NASDAQ:AVGR)’s share price gapped up before the market opened on Monday . The stock had previously closed at $0.30, but opened at $0.35. Avinger shares last traded at $0.34, with a volume of 611,563 shares traded.
Separately, Zacks Investment Research lowered Avinger from a “buy” rating to a “hold” rating in a research report on Monday, July 17th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $5.00.
The firm’s market cap is $8.09 million. The firm has a 50 day moving average price of $0.31 and a 200 day moving average price of $0.31.
An institutional investor recently bought a new position in Avinger stock. AWM Investment Company Inc. bought a new stake in shares of Avinger, Inc. (NASDAQ:AVGR) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 1,150,000 shares of the medical device company’s stock, valued at approximately $516,000. AWM Investment Company Inc. owned about 4.81% of Avinger as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 15.37% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Avinger, Inc. (AVGR) Shares Gap Up to $0.35” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/avinger-inc-avgr-shares-gap-up-to-0-35/1650043.html.
Avinger Company Profile
Avinger, Inc is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system.
Receive News & Ratings for Avinger Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.